Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 16.100M	--
--	2024/Q4	-- / 27.316M	--
Nov 12, 2024	2024/Q3	16.868M / 15.424M	--
Aug 5, 2024	2024/Q2	14.256M / 15.307M	--
May 13, 2024	2024/Q1	14.503M / 13.950M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 16.100M--

--2024/Q4-- / 27.316M--

Nov 12, 20242024/Q316.868M / 15.424M--

Aug 5, 20242024/Q214.256M / 15.307M--

May 13, 20242024/Q114.503M / 13.950M--

Unlock Free Earnings Estimates

Open Account

Theravance Biopharma Earnings Reports

Theravance Biopharma | 10-Q: Q3 2024 Earnings Report

Nov 14 06:11 ET

Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Third Quarter 2024 Financial Results and Announces Initiatives to Unlock Shareholder Value

Nov 12 16:14 ET

Theravance Biopharma | 10-Q: Q2 2024 Earnings Report

Aug 8 17:00 ET

Theravance Biopharma | 8-K: Theravance Biopharma, Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 5 16:18 ET

Trending US Stocks